Tobacco has imposed a terrible toll on global health, but it could be used to produce the molecules we need to fight COVID-19.
Rigor académico, oficio periodístico
Artículos sobre Coronavirus insights
Mostrando 1021 - 1040 de 1079 artículos
In lower-income countries, 50-day cycles of lockdown with relaxed periods in between could strike a balance between controlling the virus and getting economies running again.
Getting the control measures right is critical.
New data shows the threat posed by COVID-19 differs significantly between people with type 1 and type 2 diabetes.
The UK government has quietly relaxed a confidentiality law that protects patient health data. Here’s why that matters.
We should make more use of randomised controlled trials – usually used in medicine – to understand which measures were effective in controlling COVID-19.
There are three features common to most forms of insomnia that can be revelatory for those living under lockdown.
More than 160 people across the UK have been keeping lockdown diaries as part of a new research project charting the pandemic.
Even Sweden is still a long way off from herd immunity.
Research suggests that children are less likely than adults to catch the virus, pass it on or fall seriously ill because of it. A progressive return of children to school is therefore advisable.
Feel like time has come to a standstill? The coronavirus crisis has prompted us to be more creative with our relations to time.
By tracing the location of millions of devices, Google has mapped the pandemic response at a scale never seen before.
Here’s what we know about immunity to COVID-19, and what that means for getting life back to normal.
There’s no evidence COVID-19 death rates are related to the genetic differences used to racialise people.
Health services are seeing a drop in people seeing urgent care for stroke patients. Here’s how you can make sure your loved ones are safe.
‘Nanobodies’ produced by the llama immune system can neutralise the virus that causes COVID-19.
A full ban on eating wildlife in China probably isn’t possible, and could encourage unregulated underground markets.
A lot depends on China and India sharing the products of their pharmacuetical manufacturing with the rest of the world.
Healthcare practitioners face a difficult situation – they have the right to be protected, but are legally required to treat patients.
Was the government correct to think that adherence would fall over time? Perhaps.
Principales colaboradores
-
Senior Research Fellow in Global Health, University of Southampton
-
Associate Professor of Bioethics, University of Portsmouth
-
Professor of Medicine, University of East Anglia
-
Professor of Public Health, University of Sheffield
-
Lecturer in Psychology, Swansea University
-
Professor in Biomedical Sciences, University of Manchester
-
Professor of Mathematics and Statistics, University of Strathclyde
-
Associate Professor in Viral Immunology, University of Birmingham
-
Senior Lecturer in Mathematical Biology, University of Bath
-
Scientific Officer, University of Leeds
-
Principal Lecturer, Microbiology and Biomedical Science Practice, Fellow of the Institute of Biomedical Science, University of Brighton
-
Consultant Neonatologist and Professor of Ethics, University of Oxford
-
Clinical Research Fellow in Viral Immunology and Veterinary Surgeon, University of Cambridge
-
Assistant Professor in Health Promotion and Policy, UMass Amherst, UMass Amherst
-
Professor of Primary Care Health Sciences, University of Oxford
